Ethics Networking Patients Pharmaceutical manufacturing 
European Pharmaceutical Review
JULY 21, 2023
In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic.
Pharma Marketing Network
JUNE 11, 2020
So I would expect we’re going to find the same type of welcoming environment, maybe even more so with the pharma marketing network brand behind us. RJ Lewis (EHS): To market to patients or physicians. If you’re a pharmaceutical company or if you’re an agency or even a consultant. That’s our vision.
Expert insights. Personalized for you.
95 
Let's personalize your content